CN101095915A - Chinese traditional medicine for treating diabetes cholecystitis - Google Patents
Chinese traditional medicine for treating diabetes cholecystitis Download PDFInfo
- Publication number
- CN101095915A CN101095915A CNA2007101183974A CN200710118397A CN101095915A CN 101095915 A CN101095915 A CN 101095915A CN A2007101183974 A CNA2007101183974 A CN A2007101183974A CN 200710118397 A CN200710118397 A CN 200710118397A CN 101095915 A CN101095915 A CN 101095915A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- portions
- cholecystitis
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 55
- 201000001352 cholecystitis Diseases 0.000 title claims abstract description 22
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 18
- 241000218176 Corydalis Species 0.000 claims description 9
- 241000628997 Flos Species 0.000 claims description 9
- 210000003038 endothelium Anatomy 0.000 claims description 9
- 239000010135 fructus aurantii immaturus Substances 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 9
- 241000407170 Curcuma Species 0.000 claims description 7
- 235000014375 Curcuma Nutrition 0.000 claims description 7
- 241000245240 Lonicera Species 0.000 claims description 7
- 241000612166 Lysimachia Species 0.000 claims description 7
- 230000000694 effects Effects 0.000 abstract description 19
- 230000008901 benefit Effects 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241000202726 Bupleurum Species 0.000 abstract 1
- 241001571764 Lysimachia christinae Species 0.000 abstract 1
- 241000245665 Taraxacum Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 235000008216 herbs Nutrition 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 15
- 239000008280 blood Substances 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 15
- 229940079593 drug Drugs 0.000 description 15
- 230000036407 pain Effects 0.000 description 15
- 210000004185 liver Anatomy 0.000 description 11
- 230000001737 promoting effect Effects 0.000 description 10
- 210000002784 stomach Anatomy 0.000 description 9
- 210000001015 abdomen Anatomy 0.000 description 7
- 210000000038 chest Anatomy 0.000 description 7
- 210000000232 gallbladder Anatomy 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 206010000087 Abdominal pain upper Diseases 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 6
- 206010023126 Jaundice Diseases 0.000 description 6
- 208000001848 dysentery Diseases 0.000 description 5
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 208000015220 Febrile disease Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 208000001780 epistaxis Diseases 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- 230000001047 pyretic effect Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 210000003932 urinary bladder Anatomy 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010046814 Uterine prolapse Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 230000002605 anti-dotal effect Effects 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000004576 sand Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010004663 Biliary colic Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010054044 Diabetic microangiopathy Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010018045 Gastroptosis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 206010061876 Obstruction Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000612119 Samolus Species 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 231100000132 chronic toxicity testing Toxicity 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 210000001096 cystic duct Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 201000009101 diabetic angiopathy Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 238000009527 percussion Methods 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 238000009666 routine test Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicament for treating diabetic cholecystitis which is prepared from more than ten kinds of Chinese medicinal herbs including Bupleurum root, dandelion, honeysuckle flower and lysimachia christinae. The medicament has the advantages of assured curative effect, safe and convenient application, no toxic and side effects, and low price.
Description
Technical field
The present invention relates to treat a kind of Chinese medicine of diabetic cholecystitis, is that a kind of diabetic cholecystitis for the treatment of is the Chinese patent medicine of raw material with the Chinese herbal medicine.Belong to the field of Chinese medicines.
Background technology
Confirmed that as far back as nineteen twenty-eight and nineteen forty-three Josin and Eisele diabetics is than easier this conclusion of trouble cholecystitis of ND.Among the interrelated data prompting NIDDM patient 27.37% concurrent chronic nonconcremental cholecystitis is arranged.Bradfordg in 1988 etc. point out that the generation of diabetic microangiopathy and vegetative nerve pathological changes and chronic nonconcremental cholecystitis is closely related.Diabetes liver illness is equivalent to scopes such as " stomachache " in the Chinese medicine, " stomachache ", " hypochondriac pain ".
" case of ring brookweed hall " pointed out: " hinder in the stomach network, thus the gastral cavilty distending pain, the sticking expectorant of vomiting." " element ask thorn heat a piece of writing " say: " the liver-heat patient, urine is yellow earlier, stomachache drowsiness fever of the body." " a Ling Shu Miraculous Pivot or Divine Axis calentura piece of writing " cloud: " calentura is held umbilicus shoot, fullness in the chest and hypochondrium under the arm." these descriptions are quite similar to biliary diseases.The clinical manifestation of primary disease is: in various degree upper right abdomen or abdominal discomfort can be arranged, and persistence dull pain, or shoulder radiation to the right are when the greasy food of oil-feed can cause stomachache so that biliary colic occurs.Health check-up can not have positive the discovery, or upper right abdominal pressure pain and percussion pain are arranged.Cause that as inflammation cystic duct blocks, then can lay one's hand on and the gallbladder of enlargement generally do not have jaundice.The traditional Chinese medical science is divided disease type Coryza Treated by Syndrome Differentiation clinically, obtains very good effect.Invent a kind of not only safety but also effective Chinese medicine preparation, be significant.
Summary of the invention
The present invention develops in conjunction with the latest modern technological scientific achievement on the basis of traditional tcm syndrome differentiation and treatment.The purpose of this invention is to provide a kind of Chinese patent medicine for the treatment of diabetic cholecystitis.Have determined curative effect, safe ready, have no side effect, cheap characteristics.
The present invention is made by the following weight proportion raw material:
1.5～6 parts of 1.5～6 parts of Rhizoma Corydalis of 1.5～6 portions of Herba Lysimachiaes of Herba Artemisiae Scopariae
1.0～4 parts of 1.0～4 portions of Flos Loniceraes of 1.0～4 parts of Herba Taraxacis of Radix Bupleuri
0.1～2 part of 1.0～4 parts of Radix Et Rhizoma Rhei of 1.0～4 portions of Radix Curcumaes of Fructus Aurantii Immaturus
0.1～2 part of 0.1～2 part of Endothelium Corneum Gigeriae Galli of 0.1～2 part of Cortex Moutan of the Radix Aucklandiae.
The weight proportion of each raw material of optimization formula of the present invention is:
2.5～3.5 parts of 2.5～3.5 parts of Rhizoma Corydalis of 2.5～3.5 portions of Herba Lysimachiaes of Herba Artemisiae Scopariae
1.5～2.5 parts of 1.5～2.5 portions of Flos Loniceraes of 1.5～2.5 parts of Herba Taraxacis of Radix Bupleuri
0.5～1.5 part of 1.5～2.5 parts of Radix Et Rhizoma Rhei of 1.5～2.5 portions of Radix Curcumaes of Fructus Aurantii Immaturus
0.5～1.5 part of 0.5～1.5 part of Endothelium Corneum Gigeriae Galli of 0.5～1.5 part of Cortex Moutan of the Radix Aucklandiae.
The weight proportion of each raw material of optimum formula of the present invention is:
3 parts of 3 parts of Rhizoma Corydalis of 3 portions of Herba Lysimachiaes of Herba Artemisiae Scopariae
2 parts of 2 portions of Flos Loniceraes of 2 parts of Herba Taraxacis of Radix Bupleuri
1 part of 2 parts of Radix Et Rhizoma Rhei of 2 portions of Radix Curcumaes of Fructus Aurantii Immaturus
1 part of 1 part of Endothelium Corneum Gigeriae Galli of 1 part of Cortex Moutan of the Radix Aucklandiae.
Drug action mechanism among the present invention is as follows:
The little hardship of the Herba Artemisiae Scopariae property of medicine, little suffering are slightly cold.Return spleen, stomach, urinary bladder channel.Has clearing away heat-damp and promoting diuresis, the effect of jaundice eliminating.Can treat jaundice, dysuria, eczema pruritus etc.(the 2146th page of Shanghai science tech publishing house second edition write by " Chinese medicine voluminous dictionary " Nanjing University of Traditional Chinese Medicine).
Sweet, the little hardship of the Herba Lysimachiae property of medicine, cold.Return liver, gallbladder, kidney, urinary bladder channel.Have heat clearing away, dampness removing, treating stranguria, calculus, antidotal effect.Can treat jaundice due to damp-heat, pyretic stranguria, oedema due to nephritis, liver, gallbladder and urinary system calculus, pyretic toxicity carbuncle, venom etc.(the 1967th page of Shanghai science tech publishing house second edition write by " Chinese medicine voluminous dictionary " Nanjing University of Traditional Chinese Medicine).
Rhizoma Corydalis property of medicine suffering, hardship, temperature.GUIXIN, liver, spleen channel.Has promoting blood circulation to remove blood stasis, the effect of promoting the circulation of QI to relieve pain.Can treat obstruction of qi in the chest and cardialgia, epigastric pain, lumbago, colicky, dysmenorrhea, amenorrhea ， mass in the abdomen, the stasis of blood stagnated and suffered from abdominal pain traumatic injury etc. puerperal.(the 1261st page of Shanghai science tech publishing house second edition write by " Chinese medicine voluminous dictionary " Nanjing University of Traditional Chinese Medicine).
Radix Bupleuri nature and flavor hardship, be slightly cold.Return liver, gallbladder meridian.Effect with reconciling superficies and interior, soothing the liver, yang invigorating.Can treat alternate attack of chill and fever, fullness in the chest and hypochondriac pain, deafness, headache and dizziness, malaria, dysentery proctoptosis, menoxenia, uterine prolapse, flu, upper respiratory tract infection, hepatitis, cholecystitis etc.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 1004th page).
Herba Taraxaci property of medicine hardship, sweet, cold.Return liver, stomach warp.Has heat-clearing and toxic substances removing, the effect of eliminating carbuncle eliminating stagnation.Can treat acute mastitis, lung abscess, acute appendicitis, mumps, scrofula, furuncle carbuncle toxin, conjunctival congestion and swelling pain, cat fever, cough, laryngopharynx swelling and pain, gastritis, enteritis, dysentery, hepatitis, cholecystitis, urinary tract infection, snake bite and insect sting, burn and scald etc.(the 3427th page of Shanghai science tech publishing house second edition write by " Chinese medicine voluminous dictionary " Nanjing University of Traditional Chinese Medicine).
The Flos Lonicerae property of medicine is sweet, and is cold.Attach to the lung and stomach meridians.Effect with heat-clearing and toxic substances removing.Can treat the heating of affection due to external wind and heat or epidemic febrile disease, heatstroke, toxic-heat and blood stasis, carbuncle furuncle, sore throat, multiple infectious disease etc.(the 1972nd page of Shanghai science tech publishing house second edition write by " Chinese medicine voluminous dictionary " Nanjing University of Traditional Chinese Medicine).
Fructus Aurantii Immaturus property of medicine hardship, suffering are slightly cold.Return spleen, stomach, large intestine channel.Have the dispelling the stagnated QI removing food stagnancy, reduce phlegm except that the effect of painful abdominal mass.Can treat and stop in stagnant, the feeling of fullness distending pain, constipation, heavy behind the dysentery, blocked-up chest, the thoracic obstruction, gastroptosis, uterine prolapse, proctoptosis etc.(the 2231st page of Shanghai science tech publishing house second edition write by " Chinese medicine voluminous dictionary " Nanjing University of Traditional Chinese Medicine).
Radix Curcumae property of medicine suffering, hardship, cold.GUIXIN, liver, gallbladder meridian.Has promoting blood circulation and stopping pain, promoting QI circulation for relieving depression, the removing heat from blood that clears away heart-fire, the effect of function of gallbladder promoting.Can treat all pains of breast abdomen side of body rib, dysmenorrhea ， mass in the abdomen, the calentura coma, demented, spit blood epistaxis, stranguria with blood, sand Stranguria, jaundice etc.(the 1855th page of Shanghai science tech publishing house second edition write by " Chinese medicine voluminous dictionary " Nanjing University of Traditional Chinese Medicine).
Radix Et Rhizoma Rhei property of medicine hardship, cold.Return stomach, large intestine, liver, spleen channel.Have attack stagnant, clearing away damp-heat, pathogenic fire purging, removing heat from blood, blood stasis dispelling, antidotal effect.Can treat the food stagnation constipation, the accumulation of heat feeling of stuffiness in chest; Damp-heat dysentery, jaundice, gonorrhea, edema abdominal distention, dysuria; Conjunctival congestion, laryngopharynx swelling and pain, aphtha of the mouth and tongue, gastropyretic vomiting; Spit blood, spitting of blood, epistaxis is had blood in stool, hematuria; Blood-retention, amenorrhea, the stagnant stomachache of the stasis of blood in puerperal ， lumps in the chest and abdomen, traumatic injury; Pyretic toxicity carbuncle and ulcer, erysipelas is scalded etc.(the 141st page of Shanghai science tech publishing house second edition write by " Chinese medicine voluminous dictionary " Nanjing University of Traditional Chinese Medicine).
Radix Aucklandiae property of medicine suffering, hardship, temperature.Return spleen, stomach, liver, lung meridian.Have promoting the circulation of QI to relieve pain, the effect of mediation intestinal stasis relieving.Can treat fullness and distention in the chest and hypochondrium, abdominal distention, vomiting is had loose bowels, and heavily waits after the dysentery.(the 480th page of Shanghai science tech publishing house second edition write by " Chinese medicine voluminous dictionary " Nanjing University of Traditional Chinese Medicine).
Cortex Moutan property of medicine hardship, suffering are slightly cold.GUIXIN, liver, kidney channel.Has clearing away heat and cooling blood, the effect of promoting blood circulation to remove blood stasis.Can treat the epidemic febrile disease pathogenic heat attacking blood system in febrile diseases, send out speckle, tell nosebleed, the calentura later stage, hot Fu Yin divided heating, osteopyrexia and fever, and amenorrhea due to stagnation of blood, dysmenorrhea, mass in the abdomen, carbuncle sore tumefacting virus falls and pounces on the pain of injury, rheumatic arthralgia etc.(the 1578th page of Shanghai science tech publishing house second edition write by " Chinese medicine voluminous dictionary " Nanjing University of Traditional Chinese Medicine).
The Endothelium Corneum Gigeriae Galli property of medicine is sweet, puckery, and is flat.Return spleen, stomach, urinary bladder channel.Have strengthening the spleen and stomach, it is long-pending to help digestion, the calculi dissolving effect.Can treat food stagnation, have loose bowels, infantile malnutrition, cholelithiasis, stranguria caused by urinary stone, sand Stranguria ， mass in the abdomen amenorrhea, sore throat tonsillitis, ulcerative gingivitis aphtha etc.(the 1684th page of Shanghai science tech publishing house second edition write by " Chinese medicine voluminous dictionary " Nanjing University of Traditional Chinese Medicine).
The present invention follows the principles of formulating prescriptions of the traditional Chinese medical science " monarch ", is monarch drug with Radix Bupleuri, Herba Artemisiae Scopariae, Herba Lysimachiae and Rhizoma Corydalis; With Herba Taraxaci, Flos Lonicerae, Fructus Aurantii Immaturus, Radix Et Rhizoma Rhei and Radix Curcumae is ministerial drug; With Cortex Moutan, the Radix Aucklandiae and Endothelium Corneum Gigeriae Galli is adjuvant.All medicines are harmonious, and are total to the tool heat clearing and damp drying, the effect of circulation of qi promoting function of gallbladder promoting.The treatment diabetic cholecystitis has determined curative effect, has no side effect taking convenience, cheap characteristics.
Clinical drug of the present invention uses the result to show that following advantage is arranged:
1, the Chinese herbal medicine each component selected for use of the present invention meets the regulation of Pharmacopoeia of People's Republic of China, utilizes the comprehensive function treatment diabetic cholecystitis of the Chinese medicine of respectively distinguishing the flavor of, and is nontoxic to human body.Show that through the acute and chronic toxicity test of animal the animal of being tested does not see any toxic reaction, its main organs does not have tangible change yet, and safety of medicine is reliable.
2, rich in proteins in the medicine of the present invention, glucose, glucuronic acid, volatile oil, pectin, fructose, organic acid, lecithin, vitamin, aminoacid also contains various trace elements such as Saponin, plant sterol and calcium, is beneficial to absorption of human body, health invigorating.
3, the present invention not only can effectively treat diabetic cholecystitis, and the prevention of diabetic cholecystitis is also had good effect, and the treatment diabetic cholecystitis has determined curative effect, has no side effect taking convenience, cheap characteristics.
For showing the therapeutic effect of medicine of the present invention, as follows through clinical test results to the treatment diabetic cholecystitis; Treatment diabetic cholecystitis patient 20 examples.Take the embodiment decoction, each 1 bag, two to three times on the one, take half an hour ante cibum.Three months is a course of treatment, take continuously three the course of treatment observe the curative effect.8 examples of fully recovering account for 40%, and 9 examples that take a turn for the better account for 45%, and invalid 3 examples account for 15%, and total effective rate reaches 85%.After three course of therapy, patient does not have any untoward reaction, and three big routine tests and hepatic and renal function detect no abnormal.
The specific embodiment
The embodiment decoction takes by weighing raw material by following weight:
3 parts of 3 parts of Rhizoma Corydalis of 3 portions of Herba Lysimachiaes of Herba Artemisiae Scopariae
2 parts of 2 portions of Flos Loniceraes of 2 parts of Herba Taraxacis of Radix Bupleuri
1 part of 2 parts of Radix Et Rhizoma Rhei of 2 portions of Radix Curcumaes of Fructus Aurantii Immaturus
1 part of 1 part of Endothelium Corneum Gigeriae Galli of 1 part of Cortex Moutan of the Radix Aucklandiae.
Preparation method is to get above-mentioned raw materials to clean roguing, dries, and is ground into granule, soaks 1 hour, puts and decocts with water secondary in the multi-function extractor, adds up the water of 10 times of amounts of medical material for the first time, decocts 1.5～2 hours, gets decocting liquid, filters.Add up for the second time the water of 7 times of amounts of medical material, decocted 1～1.2 hour, get decocting liquid twice, filter, in the heat-sealing bag, 105 ℃ of high temperature sterilizes, packing is promptly.The decoction of the treatment diabetic cholecystitis that the present invention makes is that plastic packaging is packed, and every bag of 210ml is oral, one time one bag, every day two to three times.Three months is a course of treatment.
Claims (3)
1, a kind of Chinese medicine of treatment diabetic cholecystitis is characterized in that it is made by the following weight proportion raw material:
1.5～6 parts of 1.5～6 parts of Rhizoma Corydalis of 1.5～6 portions of Herba Lysimachiaes of Herba Artemisiae Scopariae
1.0～4 parts of 1.0～4 portions of Flos Loniceraes of 1.0～4 parts of Herba Taraxacis of Radix Bupleuri
0.1～2 part of 1.0～4 parts of Radix Et Rhizoma Rhei of 1.0～4 portions of Radix Curcumaes of Fructus Aurantii Immaturus
0.1～2 part of 0.1～2 part of Endothelium Corneum Gigeriae Galli of 0.1～2 part of Cortex Moutan of the Radix Aucklandiae.
2, a kind of Chinese medicine of treatment diabetic cholecystitis according to claim 1, wherein the weight proportion of each raw material is:
2.5～3.5 parts of 2.5～3.5 parts of Rhizoma Corydalis of 2.5～3.5 portions of Herba Lysimachiaes of Herba Artemisiae Scopariae
1.5～2.5 parts of 1.5～2.5 portions of Flos Loniceraes of 1.5～2.5 parts of Herba Taraxacis of Radix Bupleuri
0.5～1.5 part of 1.5～2.5 parts of Radix Et Rhizoma Rhei of 1.5～2.5 portions of Radix Curcumaes of Fructus Aurantii Immaturus
0.5～1.5 part of 0.5～1.5 part of Endothelium Corneum Gigeriae Galli of 0.5～1.5 part of Cortex Moutan of the Radix Aucklandiae.
3, a kind of Chinese medicine of treatment diabetic cholecystitis according to claim 1, wherein the weight proportion of each raw material is:
3 parts of 3 parts of Rhizoma Corydalis of 3 portions of Herba Lysimachiaes of Herba Artemisiae Scopariae
2 parts of 2 portions of Flos Loniceraes of 2 parts of Herba Taraxacis of Radix Bupleuri
1 part of 2 parts of Radix Et Rhizoma Rhei of 2 portions of Radix Curcumaes of Fructus Aurantii Immaturus
1 part of 1 part of Endothelium Corneum Gigeriae Galli of 1 part of Cortex Moutan of the Radix Aucklandiae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007101183974A CN101095915A (en) | 2007-07-05 | 2007-07-05 | Chinese traditional medicine for treating diabetes cholecystitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007101183974A CN101095915A (en) | 2007-07-05 | 2007-07-05 | Chinese traditional medicine for treating diabetes cholecystitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101095915A true CN101095915A (en) | 2008-01-02 |
Family
ID=39010138
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2007101183974A Pending CN101095915A (en) | 2007-07-05 | 2007-07-05 | Chinese traditional medicine for treating diabetes cholecystitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101095915A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102973890A (en) * | 2012-12-04 | 2013-03-20 | 宁夏易欣回药科技有限公司 | Traditional Chinese medicine composition for treating cholecystitis gall-stone |
| CN103191361A (en) * | 2013-04-11 | 2013-07-10 | 上海浦东高星生物技术研究所 | Cholagogic depression-resolving granule |
| CN104000886A (en) * | 2014-05-07 | 2014-08-27 | 马文泉 | Externally applied Chinese herbal application plaster for treating cholecystitis |
-
2007
- 2007-07-05 CN CNA2007101183974A patent/CN101095915A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102973890A (en) * | 2012-12-04 | 2013-03-20 | 宁夏易欣回药科技有限公司 | Traditional Chinese medicine composition for treating cholecystitis gall-stone |
| CN103191361A (en) * | 2013-04-11 | 2013-07-10 | 上海浦东高星生物技术研究所 | Cholagogic depression-resolving granule |
| CN104000886A (en) * | 2014-05-07 | 2014-08-27 | 马文泉 | Externally applied Chinese herbal application plaster for treating cholecystitis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101129723A (en) | Chinese medicine preparation for treating constipation | |
| CN101129766A (en) | Chinese medicine preparation for treating constipation | |
| CN103977218A (en) | Traditional Chinese medicine ointment for treating clavus | |
| CN101085314A (en) | Chinese patent medicine for treating delayed menstruation | |
| CN101095780A (en) | Chinese traditional medicine preparations for treating diabetes fatty liver | |
| CN101129923A (en) | Traditional Chinese medicine preparation for treating endometritis | |
| CN101095915A (en) | Chinese traditional medicine for treating diabetes cholecystitis | |
| CN101129627A (en) | Traditional Chinese medicine formulated product for treating post partum toxin fever | |
| CN101095779A (en) | Chinese patent drug for treating diabetes erysipelas | |
| CN101129529A (en) | Traditional Chinese medicine formulated product for treating post partum blood stasis fever | |
| CN101066429A (en) | Chinese medicine for treating breast distending pain during menstruation | |
| CN101129679A (en) | Chinese medicine composition for treating constipation | |
| CN101085313A (en) | Traditional Chinese medicine preparation for treating vicarious menstruation | |
| CN101095913A (en) | Chinese medicine preparation for treating diabetes cholecystitis | |
| CN101085281A (en) | Traditional Chinese medicine for curing chronic nephritis | |
| CN101095919A (en) | Chinese patent drug for treating diabetes gallstone | |
| CN101085312A (en) | Traditional Chinese medicine for treating hyperdyroidism | |
| CN101095922A (en) | Chinese traditional medicine composition for treating diabetes peripheral neuritis | |
| CN101095920A (en) | Chinese traditional medicine composition for treating diabetes cholecystitis | |
| CN101129901A (en) | Traditional Chinese medicine composition for treating hysteromyoma | |
| CN101095772A (en) | Chinese traditional medicine preparations for treating diabetic furuncle | |
| CN101129724A (en) | Traditional Chinese medicine formulated product for treating salpingitis | |
| CN101085254A (en) | Traditional Chinese medicine for treating uric acid nephritis | |
| CN101095806A (en) | Chinese medicine preparation for treating diabetes skin pruritus | |
| CN101095864A (en) | Chinese traditional medicine composition for treating diabetes cholecystitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20080102 |